Call for Abstracts for the 2005 Annual Meeting
Each year, members of the ATOD Section have the opportunity to present papers and research results during the Annual Meeting of the American Public Health Association. The Section typically sponsors over 70 Scientific and Poster Sessions, during which about 500 oral and poster presentations are made. Preparations are being made now for the 2005 Annual Meeting in New Orleans, LA, November 5-9, 2005. The overall theme of the convention will be “Evidence Based Policy and Practice”, which pertains to numerous topics in our field.
The ATOD section invites abstracts in all areas pertaining to:
alcohol
tobacco
other drugs
- ** WITHDRAWN papers **
- ** Waiting List for Oral Sessions**
- ** Waiting List for Poster Sessions**
- A Billion Dollars Later: Challenges in Assessing the Impact of the National Youth Anti-Drug Media Campaign
- ATOD Committee Meeting I
- ATOD Committee Meeting II
- ATOD Invited Late Breaker Session II
- ATOD Invited Late Breaker Session III
- ATOD Section Awards Ceremony and Business Meeting
- ATOD Section Council Meeting I
- ATOD Section Council Meeting II
- ATOD Section Council Meeting III
- Advocating Tobacco Control Poster Session
- Alcohol - Advocacy
- Alcohol - In General Part I
- Alcohol - In General Part II
- Alcohol - Policy
- Alcohol - Treatment
- Alcohol Consumption Distributions: Interventions and Policies Poster Session
- Alcohol Screening and Brief Intervention: Translating Research into Practice
- Alcohol and Other Drugs
- Alcohol, Tobacco and Other Drugs - Misc., Part I
- Alcohol, Tobacco and Other Drugs - Misc., Part II
- All Tied Together: SBIRT a Continuum of Care and Policy
- Around the Community and Around the Globe: Alcohol Issues in Special Populations and in the International Community Poster Session
- Bad Combination: Alcohol and Other Drugs Poster Session
- Books, Booze, and Broken Lives: Drinking on Campus
- Club Drugs
- College Students, Youth, and Tobacco Poster Session
- Communities, Colleges, and Courts: Environmental Alcohol Approaches
- Comprehensive Approach to Fetal Alcohol Spectrum Disorders: The New Jersey Model.
- Cultural Competence: Understanding Smoking in Special Populations Poster Session
- Data Measurement and Substance Abuse Treatment Services Research Poster Session
- Disparities in the Consequences of Drug Use among Minority Populations: Need for Culture-Specific Interventions
- Drinking Patterns in Special Populations: Innovative Approaches
- Emerging Issues in Tobacco Control
- Emerging Trends in Drinking Patterns and Policy Implications
- Especially Made for You and Me: Alcohol Ads and Youth Poster Session
- Evidence-Based Practices at SAMHSA
- Evidence-Based Practices in Substance Abuse Treatment
- Evidence-Based Practices in Substance Use Dependence Treatment: Challenges and Lessons Learned
- Evidence-Based Substance Abuse Prevention
- Extinguishing Myths about Smoke-Free Mental Health/Substance Abuse Facilities
- Federal Funding Priorities Breakfast
- From High School through College: The ABC's of Alcohol Use and Abuse Poster Session
- Genital Herpes Epidemic: Rethinking Testing, Treatment, and Prevention
- Global Alcohol Late Breaker Session
- HIV and HCV Prevention for Young Adult IDUs: Findings from the CIDUS III/ Drug Users Intervention Trial (DUIT)
- Healthcare Providers' Role in Smoking Cessation Poster Session
- Injection Drug Use: HIV and Hepatitis Poster Session
- Injection Drug Users
- Injection Drug Users: Risky Behaviors and Risk Reduction Poster Session
- Inside Look at Big Tobacco Poster Session
- International Findings in Substance Abuse and Treatment Poster Session
- International Tobacco Control Issues Poster Session
- Issues in Substance Abuse Poster Session
- Issues in Tobacco Control and Prevention Poster Session
- Legislating Tobacco: Analysis of Federal and State Laws Poster Session
- Litigation and Lawsuits: Next New Wave in Tobacco Policy
- Marijuana
- Measures and Interventions for At-Risk Populations Poster Session
- Medical Marijuana: Why This Issue Is More Important to Health Care Than Just Cannabis
- Meet the ATOD Leadership Reception
- Methamphetamine: An Overview and Introduction to the Treatment System
- Military and Tobacco Promotional and Cessation Efforts
- New Findings on Opioid Injection Initiation and Treatment
- No Smoking! Controlling Exposure to Environmental Tobacco Smoke Poster Session
- Nurses and Tobacco
- Patterns of Substance Use Among Adults Poster Session
- Performance Measurement and Performance Management For Substance Abuse Treatment
- Pharmacists’ Role in the Community Management of Opioid Dependence
- Policy Issues in Substance Abuse Treatment
- Prescription Drug Abuse Attitudes and Behaviors
- Prescription and OTC Drugs
- Preventing Alcohol-Related Problems through Effective Policies
- Problem Products & Problem Outlets: Issues and Strategies Regarding Alcohol Sales at the Community Level
- Promoting Tobacco-Free Environments at School and in the Home Poster Session
- REJECTED, Duplicative or Withdrawn Abstracts
- Recently Found Consequences of Substance Abuse
- Recovery from Substance Abuse and Addiction
- Reducing Drinking and Driving in North America
- Reducing Drinking and Driving in North America
- Risk and Protective Factors for Adolescent Substance Use
- Role of Ethnicity, Gender, and Development in Drug Use, Violence, and HIV Risk
- Roundtable Discussions on Ethnicity, Gender and Drug Use
- Smoking Cessation Interventions in Special Populations
- Smoking Cessation Poster Session I
- Smoking Cessation Poster Session II
- Smoking Cessation Poster Session III
- Smoking Oversees: International Tobacco Use Prevalence
- Substance Abuse Treatment Services Research and Descriptive Studies Poster Session
- Substance Abuse Treatment Systems Research Poster Session
- Taking a Systems Approach to Tobacco Research: Modeling Dynamic Processes for a Complex World
- The Good, the Bad and the Ugly: Is the Tobacco Industry Giving Social Responsibility a Bad Name?
- Tobacco - Advocacy
- Tobacco - Cessation I
- Tobacco - Cessation II
- Tobacco - In General I
- Tobacco - In General II
- Tobacco - In General III
- Tobacco - Media
- Tobacco - Policy I
- Tobacco - Policy II
- Tobacco - Policy III
- Tobacco - Prevention I
- Tobacco - Prevention II
- Tobacco Control Issues in Special Populations Poster Session
- Tobacco Control and Government at the Federal, State, and Local Levels
- Tobacco Prevention Challenges and Tobacco Control Disparities Among American Indian, Amish, Appalachian, and Asian-American Ethnic Communities and Special/Regional Populations
- Tobacco Quitlines and Websites Poster Session
- Tobacco Use in Arab American Adolescents: A Five-Year Clinical Trial
- Tobacco Use in Young Adults
- Trade and Tobacco
- Transdisciplinary Approach to Integrating Primary Care and Behavioral Health
- Translating Evidence-Based Science to Service: Clinical and infrastructure Innovations for Co-Occurring Mental Health and Substance Use Disorders
- Treatment Services Research: Consequences of Change
- Trends in Tobacco
- Trends, Patterns, and Correlates of Adolescent Substance Use Poster Session
- Trends, Patterns, and Correlates of Adolescent Substance Use Poster Session II
- U.S. Patterns of Club Drug Use
- Update on the Medicare Prescription Drug Benefit
- We Have It in Writing: Marketing Strategies from Tobacco Industry Documents
- What Do Alcohol, Tobacco, Other Drugs, Physical Inactivity, and Mental Health Disorders Have in Common?
- What's Going on Here? Measuring Components for Tobacco Control
- Where's the Evidence: Reducing the Harm of Harm Reduction Products
- Who's Smoking? Tobacco Use Trends among Adolescents and Young Adults Poster Session
- Other Drugs - In General
- Other Drugs - Prevention
- Other Drugs - Treatment I
- Other Drugs - Treatment II
The Section encourages members interested in health services research, media, advocacy, public policy, prevention and treatment practice to submit abstracts for 2005. Topics of particular interest include:
· Prevention measures that address all addictive substances and access by minors
· Models of science-based prevention and coordinated community and legal action
· Advocacy in all venues
· Early detection and screening for substance use in various settings
· Integration of substance use treatment with mental or physical health care
· Relationship of substance use and health outcomes
· Special problems of special populations
· Effective treatment and aftercare in all settings and for all problems
· International comparisons and impacts
· Best practices in prevention, screening, treatment and aftercare
· Evaluations, performance measures, and cost-effectiveness studies
This year the Program Committee will select the best student abstract submitted, and it’s authors will receive the new Award for Best Student Abstract in November.
Abstracts are submitted electronically through the APHA Web site, < www.apha.org >. The Web site provides complete instructions on the length and format of abstracts and the information required on authors. Electronic submission is scheduled to open mid-December, 2005. The deadline for submissions is on February 12, 2005.
Abstracts may be designated “Oral Only”, “Poster Only”, or “No Preference”. Last year, the ATOD Section received about 600 abstracts and were not able to accept all submissions, and that is likely to continue. Many excellent abstracts were not accepted because they were marked “Oral Only” when the Program Committee selected the specific topic for a poster session due to the large number of high quality submissions. Fewer slots are available for oral presentations than for posters, and you are encouraged to designate your abstract “No Preference”. Please give the Program Committee as many options as possible to accept your presentation.
The ATOD Section ranks abstracts through a multi-tier peer review process. Abstracts are evaluated on importance (does the presentation provide new findings and/or innovative ideas with significant impact on policy, practice or advocacy in the ATOD field?), methodological/project soundness (is the methodology sound, clearly stated, and appropriate to the topic or project? Are the sample and data and/or the population and community recent, representative, unbiased and of adequate size?), and clarity (is the content communicated in a clear, logical and understandable way?), as well as relation to overall Section priorities. Topical sessions are then assembled from high-ranked abstracts. Please note that APHA suggests the program include only one presentation by any individual, and the Section endeavors to abide by this guideline.
Session Proposals. Proposals for entire sessions (90 minutes in length and at least five presentations) may be submitted for multiple analyses or results from large data sets or projects. They will be ranked in competition with separately submitted abstracts, and the session topic will be weighed against the topics of interest for the Annual Meeting as well as the topics addressed in separately submitted abstracts. The Program Committee reserves the right to break session proposals apart and consider the individual abstracts separately without prior notification to the session organizer.
Only session proposals which include abstracts for each presentation, an overall session abstract, and have the Confex-assigned ID numbers for abstracts in the session inserted into every abstract, will be considered. The session abstract must include the rationale, moderator, presentation titles, order and length of time for each presentation, and be clearly labeled SESSION ABSTRACT - “your proposed title” on the electronic submission. Each individual abstract should also include the session title and contact information (phone and e-mail) for the person in charge of sessions so we can contact you easily.
Notification of acceptance or rejection for all abstracts submitted is sent in May by e-mail to the contact person designated in the abstract submission. Presenters are notified of date, time and location of their sessions during the summer. Should you withdraw an accepted abstract, the Program Chair will select a replacement; please do not provide a substitute. Information detailing the ATOD Section’s Preliminary Program and Final Program will be available on the ATOD Section Web site and copies of the Final ATOD Section Program including locations and last-minute changes will be available at the ATOD Section Booth.
Program Planner Contact Information:
Barry Bleidt, PhD, PharmD, RPh
Professor, Social and Administrative Sciences
School of Pharmacy Loma Linda University
PO Box 578
Loma Linda, CA 92354
Phone: 757-593-7245
E-mail:
|